LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits
LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230207005645/en/
Five new LeviSelect Immune Cell Kits enable targeted enrichment of CD3 T Cells, CD4 T Cells, CD8 T Cells and Pan B Cells. Additional kits are also available under early access. (Graphic: Business Wire)
LeviSelect Kits are a targeted expansion of the revolutionary LeviCell™ Advanced Workflow fully integrated protocol that delivers an important new approach to cellular isolation and analysis, offering:
- Cells of interest are entirely label-free, unmodified or unperturbed with no gene expression or activation changes
- Live-cell enrichment, debris removal, and targeted selection all occur in a single simple step with no additional purifications, filtrations or consumables required
- Multiple LeviSelect kits can be multiplexed for a powerful and extremely targeted approach
For oncology or immuno-oncology research, LeviSelect CD45 Depletion Kits provide a highly effective method for the enrichment of pure tumor cells enabling characterization for drug discovery and biomarker identification.
LeviSelect Immune Kits support target selection of the immune subpopulations required for downstream cell analysis or further subsetting. Researchers can enrich hematopoietic populations quickly without lengthy workflows or potential cell activation.
- CD3 Enrichment
- CD4 Enrichment
- CD8 Enrichment
- Pan B Enrichment
- Pan Monocyte Enrichment
- NK Cell Enrichment
- Neutrophil Enrichment
Now T Cells, B Cells, NK Cell and Monocytes can be enriched simultaneously with viable cell enrichment in an untouched and unbiased manner. Future LeviSelect kits will include subtypes from these major populations.
“With the immediate launch of seven LeviSelect Kits—and six more available via our Early Access program—LevitasBio is enabling the streamline enrichment of these cells for downstream cell-based assays or immune profiling studies,” stated Martin Pieprzyk, CEO of LevitasBio. “This is highly impactful to catalyze novel discoveries in both academic and biopharma discovery research.”
Researchers, scientists, and labs who would like exclusive, priority access to future LeviSelect Kits can join the LevitasBio Early Access Program at https://levitasbio.com/early-access-program.
LevitasBio —True Biology Begins Here
Our mission is to advance science and human health by providing researchers with new and powerful methods of cellular analysis. LevitasBio delivers the first truly novel approach to cellular analysis in 30 years. Our proprietary label-free levitation technology enables researchers to rescue and achieve higher quality and quantity of cells without introducing bias, high pressure, or modifications to gene expression profiles, ensuring the integrity of downstream data and analysis is maintained.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230207005645/en/
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Statement by SES S.A.29.3.2023 16:47:00 EEST | Press release
In response to rumours in the market, SES S.A. confirms that the company has engaged in discussions regarding a possible combination with Intelsat. At this stage, there can be no certainty that a transaction would materialise. The Board of SES remains fully committed to acting in the best interest of SES and its shareholders. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connec
Advent Technologies' Chairman and CEO, Dr. Vasilis Gregoriou Elected as Chair of EU IPCEI Hy2Tech Group29.3.2023 16:03:00 EEST | Press release
Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in the fuel cell and hydrogen technology sectors, is pleased to announce the election of its Chairman and CEO, Dr. Vasilis Gregoriou, as the Chair of the Important Project of Common European Interest (“IPCEI”) Hy2Tech Facilitation Group (the “Facilitation Group”). The election took place at the 1st General Assembly for Hy2Tech and Hy2Use, two of the European Union's IPCEIs, which aim to promote research, innovation, and the first industrial deployment of hydrogen technology infrastructure in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230329005582/en/ Dr. Vasilis Gregoriou (Chairman and CEO, Advent Technologies) during the 1st General Assembly for Hy2Tech and Hy2Use in Berlin, Germany. (Photo: Business Wire) The General Assembly was held on March 28, 2023 in Berlin, and was jointly organized by the German Federal Ministry for Economic Af
FarEye and Syscons Partner to Deliver a Unified Last-mile Consumer Experience29.3.2023 16:00:00 EEST | Press release
FarEye today announced a strategic partnership with Syscons to deliver a streamlined, end-to-end pre- and post-purchase last-mile delivery experience for retailers, fashion brands and manufacturers in Europe. The FarEye delivery management platform becomes part of Syscons’ supply chain and omnichannel solutions they support and implement, with the aim to simplify and expedite customers’ implementations, leading to faster time-to-market and increased value on their investments. FarEye will work closely with Syscons with customers particularly in Southern Europe to deploy their last-mile solutions. FarEye will work with both divisions of Syscons Group - Syscons Interactive and Syscons Industries- which supports fashion brands and retailers in their digital transformation journey and manufacturers in their direct-to-consumer transformation journey. Together, the companies will provide a superior last-mile technology platform with Syscons’ omnichannel portfolio for a complete end-to-end co
Vaultree Achieves Google Cloud Ready - AlloyDB Designation29.3.2023 16:00:00 EEST | Press release
Vaultree, the Data-In-Use Encryption leader, today announced that it has successfully achieved Google Cloud Ready - AlloyDB designation for AlloyDB for PostgreSQL, Google Cloud’s newest fully managed PostgreSQL-compatible database service for most demanding enterprise database workloads. This market-expanding milestone follows Vaultree’s successful $12.8 million series A funding round, selection as the only Irish recipient of the European Innovation Council (EIC) grant and the appointment of renowned tech industry veteran Rinki Sethi to its executive board of directors. Google Cloud Ready - AlloyDB is a new designation for the solutions of Google Cloud’s technology partners that integrate with AlloyDB. These partners have closely collaborated with Google Cloud to add support for AlloyDB into their solutions and tune their existing functionality for optimal outcomes. This designation recognizes the partner solutions that have met a core set of functional requirements and been validated
Planview and UiPath Partner to Optimize Test Automation with Value Stream Management Capabilities29.3.2023 16:00:00 EEST | Press release
Planview, the leading platform for connected work from portfolio planning to delivery, today announced a new strategic collaboration with UiPath (NYSE: PATH), a leading enterprise automation software company. The integration is designed to fuse the UiPath Business Automation Platform with the Planview market-shaping Value Stream Management (VSM) solution Planview® Tasktop Hub. By combining UiPath Test Suite and VSM, teams can improve the automation of repetitive and time-consuming tasks, reduce manual errors, and accelerate the delivery of their products. “Our collaboration with UiPath is a game-changer for technology leaders looking to solve efficiency and visibility challenges,” said Louise K. Allen, Chief Product Officer, Planview. “Rapid and continuous automation testing is no longer a nice-to-have; it’s critical to accelerating digital transformation and fostering the future of connected work. A recent Planview report found that bottlenecks frequently happen at the end of the rele
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom